Identity
HGNC
LOCATION
1q23.3
LOCUSID
ALIAS
CD16,CD16A,FCG3,FCGR3,FCGRIII,FCR-10,FCRIII,FCRIIIA,IGFR3,IMD20
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 2214
MIM: 146740
HGNC: 3619
Ensembl: ENSG00000203747
Variants:
dbSNP: 2214
ClinVar: 2214
TCGA: ENSG00000203747
COSMIC: FCGR3A
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA10004 | adalimumab | Chemical | ClinicalAnnotation | associated | PD | 24048425, 27044681 | |
| PA10040 | cetuximab | Chemical | ClinicalAnnotation | associated | PD | 17704420, 23296156, 27897268, 28719596, 30318772 | |
| PA164743704 | antithymocyte globulin | Chemical | ClinicalAnnotation | associated | 24322002 | ||
| PA165292659 | tocilizumab | Chemical | ClinicalAnnotation | associated | PD | 30457672 | |
| PA165817016 | Kidney Transplantation | Disease | ClinicalAnnotation | associated | 24322002 | ||
| PA443434 | Arthritis, Rheumatoid | Disease | ClinicalAnnotation | associated | PD | 19005160, 23505228, 25823782, 26167726, 30457672 | |
| PA443560 | Breast Neoplasms | Disease | ClinicalAnnotation | associated | PD | 18347005, 21109570 | |
| PA444841 | Lymphoma, Follicular | Disease | ClinicalAnnotation | associated | PD | 12975461, 16609067, 19018870 | |
| PA444845 | Lymphoma, Non-Hodgkin | Disease | ClinicalAnnotation | associated | PD | 12975461, 16609067, 19018870 | |
| PA445062 | Neoplasms | Disease | ClinicalAnnotation | associated | PD | 17704420, 23296156, 27897268, 28719596, 30318772 | |
| PA445109 | Neuromyelitis Optica | Disease | ClinicalAnnotation | associated | PD | 23505228, 26167726, 30457672 | |
| PA445451 | Psoriasis | Disease | ClinicalAnnotation | associated | PD | 24048425, 27044681 | |
| PA446304 | Lymphoma, B-Cell | Disease | ClinicalAnnotation | associated | PD | 12975461, 16609067, 19018870 | |
| PA446313 | Lymphoma, Large-Cell, Diffuse | Disease | ClinicalAnnotation | associated | PD | 12975461, 16609067, 19018870 | |
| PA449515 | etanercept | Chemical | ClinicalAnnotation | associated | PD | 24048425, 27044681 | |
| PA451261 | rituximab | Chemical | ClinicalAnnotation | associated | PD | 12975461, 16609067, 19018870, 23505228, 26167726, 30457672 | |
| PA451743 | trastuzumab | Chemical | ClinicalAnnotation | associated | PD | 18347005, 21109570 | |
| PA452639 | infliximab | Chemical | ClinicalAnnotation | associated | PD | 19005160, 24048425, 25823782, 27044681 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37461339 | 2024 | Impact of HLA Class I Antigen, Killer Inhibitory Receptor, and FCGR3A Genotypes on Breast Cancer Susceptibility and Tumor Stage. | 0 |
| 38422319 | 2024 | Association of NK cell subsets and cytotoxicity with FCGR3A gene polymorphism in functional NK cell deficiency. | 0 |
| 37461339 | 2024 | Impact of HLA Class I Antigen, Killer Inhibitory Receptor, and FCGR3A Genotypes on Breast Cancer Susceptibility and Tumor Stage. | 0 |
| 38422319 | 2024 | Association of NK cell subsets and cytotoxicity with FCGR3A gene polymorphism in functional NK cell deficiency. | 0 |
| 36746935 | 2023 | FcγRIIIA activation-mediated up-regulation of glycolysis alters MDSCs modulation in CD4(+) T cell subsets of Sjögren syndrome. | 5 |
| 36997584 | 2023 | Analysis of FCGR3A-p.176Val variants in women with recurrent pregnancy loss and the association with CD16a expression and anti-HLA antibody status. | 0 |
| 37114884 | 2023 | Association between the functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to biologics in rheumatoid arthritis patients: A meta-analysis. | 1 |
| 37149714 | 2023 | Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis. | 0 |
| 37669308 | 2023 | Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism. | 0 |
| 36746935 | 2023 | FcγRIIIA activation-mediated up-regulation of glycolysis alters MDSCs modulation in CD4(+) T cell subsets of Sjögren syndrome. | 5 |
| 36997584 | 2023 | Analysis of FCGR3A-p.176Val variants in women with recurrent pregnancy loss and the association with CD16a expression and anti-HLA antibody status. | 0 |
| 37114884 | 2023 | Association between the functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to biologics in rheumatoid arthritis patients: A meta-analysis. | 1 |
| 37149714 | 2023 | Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysis. | 0 |
| 37669308 | 2023 | Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism. | 0 |
| 34932854 | 2022 | FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer. | 1 |
Citation
Dessen P
FCGR3A (Fc fragment of IgG receptor IIIa)
Atlas Genet Cytogenet Oncol Haematol. 2007-09-01
Online version: http://atlasgeneticsoncology.org/gene/49750/fcgr3a
